MedTrace Logo

Liposomal Bupivacaine vs Adductor Canal Block in Total Knee Arthroplasty

NCT02863120 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2020-10-08

No results posted yet for this study

Summary

This study is being done to evaluate the outcomes of patients undergoing total knee replacement with two different methods of local pain control:shots of liposomal bupivacaine, a long acting anesthetic, directly into the knee during surgery or anesthetic delivered continuously to the adductor canal to provide long term pain relief. The goal is to try to find a standard protocol that provides the greatest pain relief for patients undergoing total knee replacement.

Conditions

Interventions

DRUG

liposomal bupivacaine

DRUG

bupivacaine HCl

DRUG

Ropivacaine

DRUG

Saline

Sponsors & Collaborators

  • Texas Orthopaedics, Sports and Rehabilitation Associates

    lead OTHER

Principal Investigators

  • Tyler D Goldberg, MD · Texas Orthopedics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02863120 on ClinicalTrials.gov